CABA (Cabaletta Bio) Buyback Yield %: -25.29 (As of Jul. 01, 2026)


CABA Cabaletta Bio Inc CABA
34 GF Score
Price $3.11
! 1 Warning Sign
View Full Analysis

What is Cabaletta Bio Buyback Yield %?

Cabaletta Bio CABA -0.48% 34 Buyback Yield % is -25.29 as of Jul. 01, 2026. GuruFocus rates CABA with a GF Score™ of 34/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, Cabaletta Bio ranks worse than 72.78% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cabaletta Bio's current buyback yield was -25.29%.

Cabaletta Bio Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Cabaletta Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabaletta Bio Buyback Yield % Chart

Cabaletta Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only -44.01 -12.06 -17.59 -9.44 -48.31

Cabaletta Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -69.19 -42.69 -48.31 -43.03

CABA vs RZLT, CCCC, OCGN: Buyback Yield % Comparison

For the Biotechnology subindustry, Cabaletta Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cabaletta Bio Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabaletta Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cabaletta Bio's Buyback Yield % falls into.


CABA
34GF Score
Cabaletta Bio Inc CABA
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabaletta Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cabaletta Bio's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 106.303) / 220.04901
=-48.31%

Cabaletta Bio's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 128.871) / 299.46425
=-43.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -25.29 mean?
Cabaletta Bio (CABA) has a Buyback Yield % of -25.29 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cabaletta Bio and its competitors. According to the industry distribution chart, Cabaletta Bio ranks #540 out of 742 companies in the Biotechnology industry, placing it in the top 72.8%.
Is Cabaletta Bio's Buyback Yield % too high?
Cabaletta Bio's current Buyback Yield % is -25.29. Based on the distribution chart, Cabaletta Bio ranks #540 out of 742 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Cabaletta Bio has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cabaletta Bio's Buyback Yield % compare to RZLT and CCCC?
According to the Biotechnology industry distribution chart, Cabaletta Bio ranks #540 out of 742 companies for Buyback Yield %. This places Cabaletta Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cabaletta Bio and its competitors. Cabaletta Bio's current Buyback Yield % is -25.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabaletta Bio stock overvalued right now?
Cabaletta Bio (CABA) has a current Buyback Yield % of -25.29. The current Buyback Yield % is -25.29. Cabaletta Bio's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cabaletta Bio (CABA), the current Buyback Yield % is -25.29 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cabaletta Bio Business Description

Other Exchanges CABA:Mexico
Address 2929 Arch Street, Suite 600, Philadelphia, PA, USA, 19104
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
34GF Score

Get the complete analysis for CABA

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.11
Price